Could a quick shot stop bleeding in the brain? major trial tests new approach
Disease control
Ongoing
This phase 3 trial tests whether a drug called recombinant factor VIIa (rFVIIa), given within 2 hours of a bleeding stroke, can improve recovery and limit brain damage. About 860 adults aged 18-80 with spontaneous intracerebral hemorrhage are enrolled. The study compares rFVIIa t…
Phase: PHASE3 • Sponsor: Joseph Broderick, MD • Aim: Disease control
Last updated May 19, 2026 11:46 UTC